Trial NCT02480010

View at ClinicalTrials.gov 
Org. Study IDs: BO17004

Last trial update was posted on 2015-09-18

MeSH Interventions

Pertuzumab

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

The study was terminated at the time of interim analysis since none of the participants showed a PSA response.

Limitations And Caveats

The study was terminated at the time of interim analysis since none of the participants showed a PSA response.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID